Health

More news - Latest news In response to the devastating impact of Hurricane Helene, U.S. health officials are urgently coordinating international efforts to import intravenous (IV) fluids. These efforts aim to mitigate severe shortages that have already led hospitals to delay surgeries and ration supplies for intensive care patients. Last month, severe flooding in western North Carolina severely damaged a key plant operated by Baxter, which produces about 60% of the U.S. supply of IV fluids. This disruption has had a profound effect on health services, affecting everything from hospital surgeries to home dialysis and nutrition for patients dependent on intravenous feeding, including premature newborns in neonatal intensive care units. The urgency has further intensified with ...

More news - Breaking news The 2024 presidential race has brought renewed attention to the health and suitability of candidates to handle the demands of the presidency. This weekend, Vice President Kamala Harris' campaign proactively addressed the issue by releasing a letter from her doctor, Dr. Joshua R. Simmons, attesting to her "excellent health." The move comes as the campaign seeks to draw a contrast with his opponent, former President Donald J. Trump, who has yet to release comparable medical information. Dr. Simmons' letter, while not a comprehensive medical report, summarizes key aspects of the Vice President's health. Ms. Harris, at 59, is noted to be managing seasonal allergies, mild nearsightedness and occasional skin hives with both over-the-counter and prescripti...

Related media - Breaking news The British government recently unveiled a major pharmaceutical collaboration with Eli Lilly to conduct a five-year study into the effects of the weight-loss drug tirzepatide, known commercially as Mounjaro. This initiative aims to determine whether such drugs could not only help people lose weight but also improve productivity levels within the workforce. In Britain, obesity is a growing concern, with around one in four adults classed as obese. This epidemic places a heavy financial burden on the National Health Service, costing billions every year. The government's new strategy suggests that tirzepatide injections could potentially be a viable solution to this problem. The study will focus in particular on the drug's ability to increase ...

More news - Breaking news The United Nations Children's Fund (UNICEF) has issued an urgent warning about the critical shortage of ready-to-use therapeutic foods (RUTF), a life-saving, nutrient-rich food essential for treating malnourished children in Africa. This shortage poses a serious risk of hunger for nearly two million children across the continent. Recently, UNICEF announced that four African countries, including Mali, Nigeria, Niger and Chad, have either completely exhausted their supplies of RUTF or are on the verge of doing so. Furthermore, there is a looming risk that eight other countries, such as South Sudan, the Democratic Republic of Congo and Uganda, will face similar shortages by mid-2025 if immediate action is not taken. RUTF is a peanut-based paste that re...

More news - Breaking news Ananda Lewis, a prominent television personality best known for her work as an MTV VJ in the 1990s, recently shared an update on her ongoing battle with breast cancer, revealing that it has progressed to stage 4. Lewis, who Initially diagnosed in 2019, he revealed during a CNN roundtable that the cancer had metastasized as early as last year. In subsequent communications, including a telephone interview with The New York Times, the 51-year-old expressed a renewed sense of optimism about her health. After resuming more aggressive treatment options, Lewis reported significant improvements, stating, "I've resolved the problem really beautifully." Lewis rose to fame on BET's "Teen Summit" before moving to MTV where she became a household name with her s...

More news - Latest news This week, a major surgical oncology division at Columbia University faced a significant setback with the retraction of five research papers and a warning note attached to a sixth, highlighting ongoing research integrity issues at inside the institution. Dr Sam Yoon, who led the division, has seen more than a dozen of his studies retracted due to questionable results since the first reports of data inconsistencies emerged earlier this year. The retractions center on allegations that Dr. Yoon and a junior researcher used duplicate images in multiple studies, falsely representing experimental results. This practice, which involves presenting data from one study as if it came from another, can significantly distort scientific results and mislead th...